Michael Yaffe News Today

The timing and dosage of DNA-damaging drugs determine whether cancer cells die or enter senescence, according to a study from the MIT Koch Institute lab of Michael Yaffe. The work suggests clinical implications for combining chemotherapy with MEK inhibitors.

Kinases are essential for cell signaling. A new study matches hundreds of kinases to their targets, enabling a deeper understanding of biological processes.

One of the most important classes of human enzymes are protein kinases -; signaling molecules that regulate nearly all cellular activities, including growth, cell division, and metabolism.

A new atlas maps more than 300 protein kinases found in human cells and identifies which types of protein substrates they target

A new atlas maps more than 300 protein kinases found in human cells, and identifies which types of protein substrates they target. The atlas could help scientists understand what happens when cells become cancerous or are treated with specific drugs.

CHICAGO: A panel of experts on Monday acknowledged that the process of pursuing justice for violations of international humanitarian law and human rights during the war in Syria faces many hurdles, and even though evidence of such crimes continues to mount it could take years for alleged perpetrators to be brought to trial.

A new study from MIT reveals that a peptide produced by some legumes helps them control nitrogen-fixing bacteria by sequestering all available heme, an iron-containing molecule. This sends the bacteria into an iron-starvation mode that ramps up their production of ammonia, the form of nitrogen that is usable for plants.

Most people in the United States have some degree of immune protection against Covid-19, either from vaccination, infection, or a combination of the two. But, just how much protection does any individual person have?

Most people in the United States have some degree of immune protection against Covid-19, either from vaccination, infection, or a combination of the two. But,

MIT researchers developed a test that may predict an individual’s immune response to SARS-CoV-2. Their test, which uses the same type of lateral flow technology as most Covid-19 antigen tests, measures neutralizing antibodies that target the SARS-CoV-2 virus in blood.